Real-time enrollment status for this brca1 gene mutation clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT04294927 |
| Recruiting Status | Recruiting |
| Condition | BRCA1 Gene Mutation |
| Phase | Clinical Trial |
| Target Enrollment | 3,000 participants |
| Active Locations | 11 sites in the US |
| Sponsor | University Medical Center Nijmegen |
| Last Updated on CT.gov | April 6, 2026 (Apr 6, 2026) |
As of July 13, 2026: Clinical trial NCT04294927 is currently recruiting participants. This clinical trial study for brca1 gene mutation is actively seeking new participants at 11 locations across the United States. The study is sponsored by University Medical Center Nijmegen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04294927 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04294927 was last updated Apr 6, 2026 (April 6, 2026). HelloStudys verifies this status automatically.